1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 30 MARCH 2015

CNS Drug News 30 MARCH 2015

  • April 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Dementia Research To See Increased Investment
Industry Brief - Opicapone Significantly Improves Off Time In Fluctuating PD Patients As Add-On To Levodopa
Industry Brief - AbbVie/C2N Enter Worldwide Licence Agreement For AD Therapy
Industry Brief - Novartis Buys Out CAD106 Licence Agreement For CHF4mn
Industry Brief - GliaCure Receives Grant For Phase Ib AD Trial
Industry Brief - EMA Validates Zinbryta MAA For MS
Industry Brief - Masitinib Receives FDA ODD For ALS
Industry Brief - FDA Grants Treeway's TW001 ODD For ALS
Industry Brief - Mesoblast Granted Japanese Patent Covering MPCs For Cardiovascular Indications
Industry Brief - CERC-301 Misses Primary Endpoint In Phase II Study For MDD
Industry Brief - Otsuka Granted Approval In Japan For New Formulation Of Abilify
Industry Brief - Pre-Filled Dual Chamber Syringe For Abilify Maintena Receives Positive CHMP Opinion
Industry Brief - Vyvanse 10mg Available In US
Industry Brief - Milestone Triggered By Advancement Of Shionogi's Abuse-Deterrent Hydrocodone
Industry Brief - Teva's TEV-48125 Meets Primary/Secondary Endpoints In Episodic Migraine Study
Industry Brief - Lyrica Phase IV Study In Adolescents With Fibromyalgia Misses Primary Endpoint
Industry Brief - PAION Initiates US Phase III Trial Of Remimazolam
Industry Brief - Aurobindo Gains Lacosamide Tentative Approval
Industry Brief - GW Initiates First Phase III Pivotal Trial For Epidiolex In Dravet Syndrome
Industry Brief - Marinus' Ganaxolone Receives FDA ODD In PCDH19 Female Epilepsy
Industry Trend Analysis - Mysimba Will Have Fewer Competitors But Sales Dampened By Safety Concerns
Industry Brief - Helsinn Receives Positive CHMP Opinion On Akynzeo For CINV Prevention
Industry Brief - Confluence/AOP Orphan To Co-Develop Fragile X Syndrome Drug
Industry Brief - Consilient Launches Pregabalin Capsules In UK
Industry Brief - Macrophage Therapeutics To Expand Efforts Into CNS Diseases
Industry Trend Analysis - Successful Diversification Will Help Newly Named Biogen Sustain Growth
Industry Brief - BioCorRx Reports Reinstatement Of LOU To Acquire Naltrexone Implant Formula

Table Of Contents

CNS Drug News 30 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023

Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Alzheimer’s disease ...

Amyotrophic lateral sclerosis (ALS)- Market Insights, Epidemiology and Market Forecast-2023

Amyotrophic lateral sclerosis (ALS)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Amyotrophic lateral sclerosis (ALS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of ...

Global Multi Infarct Dementia Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global Multi Infarct Dementia Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

  • $ 3900
  • Industry report
  • November 2016
  • by Occams

"Global Multi Infarct Dementia Market Research Report 2016" by OBRC, is an extensive study on present state of the Multi Infarct Dementia Market. The global multi-infarct dementia is estimated to reach ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.